Treace Medical Concepts, Inc. (TMCI)

NASDAQ: TMCI · Real-Time Price · USD

3.460

+0.380 (12.34%)

At close: May 29, 2026, 4:00 PM EDT

3.490

+0.030 (0.87%)

After-hours: May 29, 2026, 7:20 PM EDT

Treace Medical Concepts Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	207.32	212.69	209.36	187.12	141.84	94.42
Revenue Growth (YoY)	-1.66%	1.59%	11.88%	31.92%	50.22%	64.59%
Cost of Revenue	42.05	42.94	41.09	35.18	25.53	16.89
Gross Profit	165.27	169.75	168.26	151.94	116.31	77.53
Selling, General & Admin	201.66	203.62	203.36	187.93	137.57	83.84
Research & Development	19.34	20.28	20.59	15.44	13.58	10.2
Total Operating Expenses	221.01	223.91	223.95	203.37	151.15	94.04
Operating Income	-55.74	-54.15	-55.69	-51.43	-34.84	-16.51
Interest Income	2.44	2.78	4.88	6.73	1.31	0.02
Interest Expense	-5.58	-5.32	-5.26	-5.17	-4.4	-4.06
Other Non-Operating Income (Expense)	-7.46	-7.15	0.27	2.24	-12.86	-4.04
Total Non-Operating Income (Expense)	-10.6	-9.7	-0.11	3.8	-15.94	-8.08
Pretax Income	-66.34	-63.85	-55.8	-47.63	-50.79	-24.59
Net Income	-61.04	-59	-55.74	-49.53	-42.82	-20.75
Net Income Attributable to Preferred Dividends	-	-	-	-	-	0.2
Net Income to Common	-61.04	-59	-55.74	-49.53	-42.82	-20.75
Shares Outstanding (Basic)	64	63	62	61	55	48
Shares Outstanding (Diluted)	64	63	62	61	55	48
Shares Change (YoY)	2.27%	1.86%	2.07%	10.09%	14.17%	30.61%
EPS (Basic)	-0.97	-0.93	-0.90	-0.81	-0.77	-0.43
EPS (Diluted)	-0.97	-0.93	-0.90	-0.81	-0.77	-0.43
Shares Outstanding	64.79	63.86	62.36	61.75	55.63	54.18
Free Cash Flow	-25.96	-29.49	-48.76	-46.03	-45.49	-19.9
Free Cash Flow Per Share	-0.41	-0.47	-0.79	-0.76	-0.82	-0.41
Gross Margin	79.72%	79.81%	80.37%	81.20%	82.00%	82.11%
Operating Margin	-26.89%	-25.46%	-26.60%	-27.48%	-24.57%	-17.49%
Profit Margin	-29.44%	-27.74%	-26.63%	-26.47%	-30.19%	-21.77%
FCF Margin	-12.52%	-13.86%	-23.29%	-24.60%	-32.07%	-21.07%
EBITDA	-46.68	-43.53	-47.27	-46.08	-32.71	-15.83
EBITDA Margin	-22.52%	-20.47%	-22.58%	-24.62%	-23.06%	-16.76%
EBIT	-55.74	-54.15	-55.69	-51.43	-34.84	-16.51
EBIT Margin	-26.89%	-25.46%	-26.60%	-27.48%	-24.57%	-17.49%

SEC Filings: 10-K · 10-Q